In addition to the IL-6/STAT3 pathway, the diverse properties of cancer cells are regulated by signaling through multiple receptors, including platelet-derived growth factor receptor (PDGF-R), epidermal growth factor receptor (EGF-R), fibroblast growth factor receptor (FGF-R), vascular endothelial growth factor receptor (VEGF-R) and insulin-like growth factor-1 receptor (IGF-1R). Here, STAT3 is linked to cancer.